🇺🇸 FDA

Intelligence · Clinical Pipeline

Oncology R&D Pipeline

Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.

Programs
5,568

Quick answer

Oncology: NovaPharmaNews indexes 5,568 oncology clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.

Top sponsors

Page 90 of 116

  1. BEZ235 + MEK162

    Pfizer

    Unspecified Adult Solid Tumor, Protocol Specific

    phase 1 small molecule completed

    1 trial

  2. BG-60366

    BEONE MEDICINES AUS PTY LTD

    Non-Small Cell Lung Cancer

    phase 1 small molecule terminated

    1 trial

  3. BG-68501

    BEONE MEDICINES AUS PTY LTD

    Breast Cancer

    phase 1 small molecule active

    1 trial

  4. BG-75098

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  5. BG-75202

    BEONE MEDICINES AUS PTY LTD

    Breast Cancer

    phase 1 small molecule active

    1 trial

  6. BG-89894

    BEONE MEDICINES AUS PTY LTD

    Advanced or Metastatic MTAP-deleted Solid Tumors

    phase 1 small molecule terminated

    1 trial

  7. BG-C0902

    BEONE MEDICINES AUS PTY LTD

    Solid Tumors

    phase 1 small molecule active

    1 trial

  8. BG-C0979

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  9. BG-C137

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  10. BG-C477

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  11. BG-C9074

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  12. BGB-15025

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  13. BGB-21447

    BEONE MEDICINES AUS PTY LTD

    Relapsed Non-Hodgkin Lymphoma

    phase 1 small molecule active

    1 trial

  14. BGB-21447

    BEONE MEDICINES AUS PTY LTD

    Hormone-receptor-positive Breast Cancer

    phase 1 small molecule active

    1 trial

  15. BGB-24714

    BEONE MEDICINES AUS PTY LTD

    Solid Tumor, Adult

    phase 1 small molecule terminated

    1 trial

  16. BGB-26808

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  17. BGB-43395

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  18. BGB-53038

    BEONE MEDICINES AUS PTY LTD

    Metastatic Solid Tumors

    phase 1 small molecule active

    1 trial

  19. BGB-58067

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  20. BGB-A3055

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule terminated

    1 trial

  21. BGB-B2033

    BEONE MEDICINES AUS PTY LTD

    Metastatic Hepatocellular Carcinoma

    phase 1 small molecule active

    1 trial

  22. BGB-B3227

    BEONE MEDICINES AUS PTY LTD

    Advanced Cancer

    phase 1 small molecule terminated

    1 trial

  23. BGB-B455

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  24. BGB-C354

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  25. BGB-R046

    BEONE MEDICINES AUS PTY LTD

    Solid Tumor

    phase 1 small molecule terminated

    1 trial

  26. BGM-2121

    Chongqing Precision Biotech Co., Ltd

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  27. BI 3011441

    Boehringer Ingelheim

    Solid Tumors, KRAS Mutation

    phase 1 small molecule completed

    1 trial

  28. BI 765063

    Boehringer Ingelheim

    Head and Neck Squamous Cell Carcinoma (HNSCC)

    phase 1 small molecule active

    1 trial

  29. BI 905711

    Boehringer Ingelheim

    Gastrointestinal Neoplasms

    phase 1 small molecule completed

    1 trial

  30. BL-M07D1

    Sichuan Baili Pharmaceutical Co.,

    Breast Cancer

    phase 1 small molecule active

    1 trial

  31. BMS-641988 (AR#2)

    Bristol-Myers Squibb

    Prostate Cancer

    phase 1 small molecule completed

    1 trial

  32. BMS-906024

    Bristol-Myers Squibb

    Cancer

    phase 1 small molecule completed

    1 trial

  33. BMS-986148

    Bristol-Myers Squibb

    Advanced Cancer

    phase 1 small molecule completed

    1 trial

  34. BMS-986500

    Bristol-Myers Squibb

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  35. BNT211, BNT211, BNT211, BNT211

    BioNTech SE

    Solid Tumors

    phase 1 small molecule active

    1 trial

  36. BNT314

    BioNTech SE

    Advanced or metastatic malignant solid tumors

    phase 1 small molecule active

    1 trial

  37. BPT567

    BRIGHT MINDS BIOSCIENCES INC.

    Advanced Solid Tumors

    phase 1 small molecule terminated

    1 trial

  38. BPX-601

    Regeneron UK Limited

    Prostate Cancer

    phase 1 gene therapy active

    1 trial

  39. BPX-601

    Regeneron UK Limited

    Metastatic Castration-resistant Prostate Cancer

    phase 1 mab terminated

    1 trial

  40. BZ019

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Large B-cell Lymphoma

    phase 1 mab active

    1 trial

  41. Beamion LUNG-1: A study to test different doses of zongertinib in people with different types of advanced cancer (solid tumours with changes in the HER2 gene)

    Boehringer Ingelheim

    Solid tumours with HER2 aberrations, Non-small cell lung cancer

    phase 1 other active

    1 trial

  42. Bemarituzumab

    Prime Medicine

    Gastrointestinal Cancer

    phase 1 mab completed

    1 trial

  43. Bempegaldesleukin (NKTR-214)

    Nektar Therapeutics UK Limited

    Metastatic Melanoma

    phase 1 mab terminated

    1 trial

  44. Bexarotene (Targretin®)

    LIGAND PHARMACEUTICALS INC

    Advanced, Malignant Aerodigestive Tract Tumor (Lung, Head and Neck and Esophagus)

    phase 1 small molecule completed

    1 trial

  45. BioTTT001 injection

    Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

    Locally Advanced Breast Cancer (LABC)

    phase 1 mab terminated

    1 trial

  46. Biological/Vaccine: therapeutic autologous dendritic cells.

    LISATA THERAPEUTICS, INC.

    Kidney Cancer

    phase 1 mab terminated

    1 trial

  47. Biological: PD-1

    Hospital Authority, Hong Kong

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  48. Brentuximab Vedotin

    Takeda

    Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic

    phase 1 small molecule terminated

    1 trial

Frequently asked questions

How many oncology pipeline programs are tracked?

5,568 programs match this therapeutic area based on indication text, program name, and registry metadata.

Where does pipeline data come from?

ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.